免疫检测市场规模、份额、成长分析、按产品、按技术、按检体、按应用、按最终用户、按地区 - 行业预测，2024-2031 年

2022年全球免疫检测市场规模将为332.6亿美元，从2023年的351.2亿美元增长到2031年的542.7亿美元，并预计在预测期内增长（2024-2024年），预计复合年增长率为5.59 2031 年的百分比）。

全球免疫检测市场是诊断产业的重要领域，因其在疾病检测、药物开发和临床研究中发挥关键作用而受到重视。由于慢性病的流行、对早期诊断工具的需求不断增加以及检测技术的进步，该市场正在显着增长。该市场的特点是技术多种多样，包括 ELISA、西方印渍术和免疫检测，每种技术都满足不同的诊断需求。免疫检测与生物感测器和奈米技术等最尖端科技的融合正在推动创新并扩大应用。此外，对个人化医疗的日益关注以及对快速、准确和经济高效的诊断解决方案的需求正在进一步推动市场成长。领先的公司正在投资研发，以提高其检测的灵敏度和特异性，为市场的持续扩张和技术进步做好准备。

目录

介绍

• 研究目的
• 定义
• 市场范围

调查方法

• 资讯采购
• 次要/一级资讯来源
• 市场规模预测
• 市场假设与限制

执行摘要

• 市场概况展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务
• 波特的分析

主要市场考察

• 市场生态系统
• 重点投资分析
• 关键成功因素
• 竞争程度
• 监管分析
• 技术分析
• 贸易分析
• 专利分析
• 价值链分析
• 供应链分析
• 价格分析

免疫检测市场：副产品

• 市场概况
• 试剂/套件
  • ELISA 试剂/套件
  • 快速检测试剂/套件
  • ELISPOT 试剂/套件
  • CLIA 试剂/套件
  • IFA 试剂/套件
  • 蛋白质印迹试剂/套件
  • 其他试剂/套件
• 分析仪
  • 分析仪，按类型
  • 开放式系统
  • 封闭式系统
  • 分析仪，按购买模式
  • 租赁购买
  • 完成购买

免疫检测市场：依技术分类

• 市场概况
• ELISA
• CLIA
• IFA
• 快速测试
• 蛋白质印迹法
• ELISPOT
• 其他技术

免疫检测市场：按检体

• 市场概况
• 血
• 唾液
• 尿
• 其他检体

免疫检测市场：依应用分类

• 市场概况
• 感染疾病
• 内分泌学
• 心臟病学
• 自体免疫疾病
• 过敏诊断
• 肿瘤学
• 骨骼/矿物质疾病
• 药物监测/测试
• 验血
• 新生儿筛检
• 其他用途

免疫检测市场：依最终用户分类

• 市场概况
• 医院/诊所
• 临床实验室
• 製药/生物技术公司/药物委外研发机构
• 居家医疗
• 血库
• 研究/学术机构

免疫检测市场规模：按地区划分

• 市场概况
• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲 (MEA)
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲地区

竞争格局

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市集活动
• 主要企业市场占有率（2023年）

主要企业简介

• Abbott Laboratories（US）
• F. Hoffmann-La Roche Ltd.（Switzerland）
• Siemens Healthineers AG（Germany）
• Danaher Corporation（US）
• Thermo Fisher Scientific Inc.（US）
• Revvity（US）
• Becton, Dickinson and Company（US）
• Diasorin SpA（Italy）
• Bio-Rad Laboratories, Inc.（US）
• QuidelOrtho Corporation（US）
• BioMerieux（France）
• Qiagen NV（Netherlands）
• Sysmex Corporation（Japan）
• Agilent Technologies, Inc.（US）
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.（China）
• Merck KGaA（Germany）
• Meridian Bioscience（US）
• Bio-Techne（US）
• Cellabs（Australia）
• Abnova Corporation（Taiwan）

Global Immunoassay Market size was valued at USD 33.26 billion in 2022 and is poised to grow from USD 35.12 billion in 2023 to USD 54.27 billion by 2031, growing at a CAGR of 5.59% in the forecast period (2024-2031).

The global immunoassay market is a critical sector within the diagnostics industry, valued for its pivotal role in disease detection, drug development, and clinical research. This market has witnessed substantial growth due to the rising prevalence of chronic diseases, increased demand for early diagnostic tools, and advancements in assay technologies. The market is characterized by a diverse range of techniques, including ELISA, Western blotting, and radioimmunoassay, each catering to various diagnostic needs. The integration of immunoassays with cutting-edge technologies such as biosensors and nanotechnology is driving innovation and expanding applications. Moreover, the growing focus on personalized medicine and the demand for rapid, accurate, and cost-effective diagnostic solutions further fuel market growth. Key players are investing in research and development to enhance assay sensitivity and specificity, positioning the market for continued expansion and technological advancement.

Top-down and bottom-up approaches were used to estimate and validate the size of the Immunoassay Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Immunoassay Market Segmental Analysis

Global Immunoassay Market is segmented on the basis of product, technology, specimen, application, end user, and region. By product, market is segmented into Reagents & Kits, Analyzers. By technology, market is segmented into ELISA, CLIA, IFA, Rapid Tests, Western Blotting, ELISPOT, and Other Technologies. By specimen, market is segmented into Blood, Saliva, Urine, and Other Specimens. By application, market is segmented into Infectious Diseases, Endocrinology, Cardiology, Autoimmune Disorders, Allergy Diagnostics, Oncology, Bone & Mineral Disorders, Drug Monitoring and Testing, Blood Screening, Newborn Screening, and Other Applications. By end user, market is segmented into Hospitals & Clinics, Clinical Laboratories, Pharmaceutical & Biotechnology Companies and Contract Research Organizations, Home Care Settings, Blood Banks, and Research & Academic Laboratories. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Immunoassay Market

One of the primary drivers of the immunoassay market is technological advancements. Innovations such as automated platforms, high-throughput screening, and the integration of artificial intelligence (AI) are significantly enhancing assay performance and efficiency. Automated systems streamline the process, reduce human error, and increase throughput, which is particularly beneficial in high-volume diagnostic settings. AI and machine learning algorithms are being utilized to interpret complex data sets, improving diagnostic accuracy and predictive capabilities. These technological improvements not only enhance the sensitivity and specificity of immunoassays but also reduce turnaround times and operational costs. The continual development of new assay formats and improvements in reagent formulations further drive the market by expanding the range of applications and enhancing overall performance.

Restraints in the Immunoassay Market

A significant restraint in the immunoassay market is the high cost associated with advanced assay systems. Sophisticated technologies, such as automated platforms and high-throughput systems, require substantial investment in terms of both initial capital and maintenance. The high costs of these systems can be prohibitive for smaller laboratories or healthcare facilities, potentially limiting their access to cutting-edge diagnostic tools. Additionally, the expense of high-quality reagents and consumables can further strain budgets. This financial barrier may hinder the adoption of advanced immunoassay technologies in emerging markets or in institutions with limited funding. Consequently, this restraint impacts the overall market growth by limiting the widespread implementation of the latest assay innovations.

Market Trends of the Immunoassay Market

A notable trend in the immunoassay market is the increasing adoption of point-of-care (POC) testing. This shift towards POC testing is driven by the need for rapid and convenient diagnostic solutions that can be administered outside traditional laboratory settings. POC immunoassays offer benefits such as immediate results, reduced need for sample transportation, and increased patient accessibility. They are particularly valuable in emergency situations, remote locations, and for monitoring chronic conditions. The development of compact, user-friendly devices with high sensitivity and specificity is fueling this trend. Additionally, advancements in microfluidics and biosensor technologies are enhancing the performance of POC assays, making them more reliable and effective. As healthcare systems seek to improve efficiency and patient outcomes, the demand for POC immunoassays is expected to continue rising.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Ecosystem of the Market
• Top Investment Analysis
• Key Success Factor
• Degree of Competition
• Regulatory Analysis
• Technology Analysis
• Trade Analysis
• Patent Analysis
• Value Chain Analysis
• Supply Chain Analysis
• Pricing Analysis

Immunoassay Market by Product

• Market Overview
• Reagents & Kits
  • Elisa Reagents & Kits
  • Rapid Test Reagents & Kits
  • ELISPOT Reagents & Kits
  • CLIA Reagents & Kits
  • IFA Reagents & Kits
  • Western Blot Reagents & Kits
  • Other Reagents & Kits
• Analyzers
  • Analyzers, By Type
  • Open-Ended Systems
  • Closed-Ended Systems
  • Analyzers, By Purchase Mode
  • Rental Purchase
  • Outright Purchase

Immunoassay Market by Technology

• Market Overview
• ELISA
• CLIA
• IFA
• Rapid Tests
• Western Blotting
• ELISPOT
• Other Technologies

Immunoassay Market by Specimen

• Market Overview
• Blood
• Saliva
• Urine
• Other Specimens

Immunoassay Market by Application

• Market Overview
• Infectious Diseases
• Endocrinology
• Cardiology
• Autoimmune Disorders
• Allergy Diagnostics
• Oncology
• Bone & Mineral Disorders
• Drug Monitoring and Testing
• Blood Screening
• Newborn Screening
• Other Applications

Immunoassay Market by End User

• Market Overview
• Hospitals & Clinics
• Clinical Laboratories
• Pharmaceutical & Biotechnology Companies and Contract Research Organizations
• Home Care Settings
• Blood Banks
• Research & Academic Laboratories

Immunoassay Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Abbott Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Revvity (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Diasorin S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QuidelOrtho Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioMerieux (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qiagen N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meridian Bioscience (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Techne (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cellabs (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abnova Corporation (Taiwan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments